Bloomberg Television·2026-08-03 17:41Pharmaceuticals and Healthcare M&A - AstraZeneca experienced a 7% stock decline following early-stage merger talks with Bristol-Myers Squibb [1][2][48] - Bristol-Myers Squibb shares increased by 2.7%, with the potential combination projected to create the world's largest drug maker generating approximately $107 billion in annual revenue [2][48] - KKR agreed to acquire Integer in an all-cash deal valued at more than $5 billion [27][86] Commodities and Precious Metals - Brent crude dropped by 5% and 5.6% as geopolitical tensions eased regarding potential conflict with Iran [24][47][118] - Standard Chartered established a gold price target of $4,200, projecting a Q3 average of $4,300 and reaching $4,650 in Q4 [188][194] Financial Markets and Asset Management - Jefferies faced exposure issues through its Point Bonita fund, with peak exposure reaching $500 million and dropping to less than $300 million [32][33] - KKR raised a record $19.2 billion for its largest-ever infrastructure mega-fund [86][88] - Major tech companies achieved massive market capitalizations, with Amazon crossing the $3-trillion market cap threshold [57][68]